News and Articles

Stories of Hope

Follow A Race Against Blindness research funding, inherited retinal disease developments, community stories, grant announcements, and updates from families racing toward sight-saving treatments.

Grant history

Hope, Funded

Every dollar below has been paid out to research, made possible by the generosity of our sponsors and donors. Real people making an impact on saving children's eyesight.

$6.1M

total research funding, fully paid out · as of October 2026

  1. 2024

    $3M awarded

    October
    $1M
    December
    $2M

    To fund the preclinical development and regulatory preparation of AXV-101, a gene therapy for Bardet-Biedl Syndrome type 1 (BBS1), advancing the program toward its first human clinical trial.

  2. 2025

    $1M awarded

    September
    $1M

    To support clinical development of the first-in-human trial, including trial preparation and regulatory progress following clinical trial clearance.

  3. 2026

    $2.1M awarded

    January
    $1.1M
    June
    $1M

    To close the remaining funding gap required to launch the AXV-101 clinical trial, enabling the study to begin in early 2026; and, through a grant to the Foundation Fighting Blindness, to fund early-stage gene therapy research with Dr. Thomas Mendel and gene-agnostic therapy (NACA) aimed at slowing vision loss in RP. A matched donor brought in an additional $775,000, bringing the total impact of that grant round to $1.55M.

Latest posts

Fundraiser stories

  1. About BBS

    Comprehensive U.S. Directory of Pediatric Retinal Disease Centers

    This directory highlights premier institutions across the United States with specialized programs for diagnosing and managing pediatric inherited retinal diseases (IRDs) such as retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis, and Bardet-Biedl Syndrome. Each listing includes the center’s website and contact information.

    Read more

All fundraiser stories